Daiwa Securities Group Inc. grew its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 3.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 164,183 shares of the conglomerate’s stock after acquiring an additional 4,714 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Danaher were worth $37,585,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds also recently modified their holdings of DHR. Sivia Capital Partners LLC boosted its position in shares of Danaher by 6.3% in the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after acquiring an additional 119 shares during the period. First Trust Advisors LP boosted its position in shares of Danaher by 34.5% in the second quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock valued at $10,947,000 after acquiring an additional 14,217 shares during the period. Main Street Financial Solutions LLC boosted its position in shares of Danaher by 40.2% in the second quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after acquiring an additional 886 shares during the period. Ieq Capital LLC raised its stake in shares of Danaher by 64.2% in the second quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after purchasing an additional 29,592 shares in the last quarter. Finally, HUB Investment Partners LLC raised its stake in shares of Danaher by 30.7% in the second quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after purchasing an additional 325 shares in the last quarter. 79.05% of the stock is owned by institutional investors.
Danaher Stock Performance
Danaher stock opened at $186.86 on Friday. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.87 and a quick ratio of 1.52. The stock has a fifty day moving average price of $181.34 and a two-hundred day moving average price of $206.35. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The firm has a market capitalization of $132.25 billion, a P/E ratio of 36.14, a P/E/G ratio of 2.38 and a beta of 0.81.
Danaher Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 0.9%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio is currently 30.95%.
Analyst Ratings Changes
A number of research analysts recently commented on DHR shares. Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research note on Saturday, April 25th. The Goldman Sachs Group cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Monday, April 13th. Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Argus cut their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research note on Friday, April 24th. Finally, Jefferies Financial Group restated a “buy” rating and issued a $245.00 target price on shares of Danaher in a research note on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $235.14.
Get Our Latest Stock Analysis on Danaher
Danaher Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
See Also
- Five stocks we like better than Danaher
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
